6-Isopropyl-6-nor-lysergic acid diethylamide
(Redirected from 6-isopropyl-6-nor-lysergic acid diethylamide)
6-Isopropyl-6-nor-lysergic acid diethylamide (IP-LAD) is an analog of lysergic acid diethylamide (LSD) developed by the team of David E. Nichols. In studies on mice, it was found to be approximately 40% the potency of LSD, compared to the 60% increase in potency seen with ETH-LAD, 2-fold potency increase of AL-LAD, and roughly equivalent potency of PRO-LAD.[1]
![]() | |
Clinical data | |
---|---|
Routes of administration | Oral |
Legal status | |
Legal status | |
Identifiers | |
| |
PubChem CID | |
ChemSpider | |
ChEMBL | |
Chemical and physical data | |
Formula | C22H29N3O |
Molar mass | 351.494 g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
References
edit- ^ Hoffman AJ, Nichols DE (September 1985). "Synthesis and LSD-like discriminative stimulus properties in a series of N(6)-alkyl norlysergic acid N,N-diethylamide derivatives". Journal of Medicinal Chemistry. 28 (9): 1252–1255. doi:10.1021/jm00147a022. PMID 4032428.